Share-Based Compensation (Tables)
|
12 Months Ended |
Dec. 31, 2023 |
|---|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|
| Share-Based Compensation Expense and Related Tax Benefits |
The table below provides the share-based compensation expense and related tax benefits for the periods indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
|
2023 |
|
|
2022 |
|
|
2021 |
|
|
|
(in thousands) |
|
Share-based compensation expense |
|
$ |
2,681 |
|
|
$ |
2,595 |
|
|
$ |
2,436 |
|
Related tax benefits |
|
$ |
808 |
|
|
$ |
752 |
|
|
$ |
703 |
|
|
| Summary of Information under Plans |
The following information under the Plans is presented for the periods indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
|
2023 |
|
|
2022 |
|
|
2021 |
|
|
|
(in thousands) |
|
Total intrinsic value of options exercised (1) |
|
$ |
343 |
|
|
$ |
20 |
|
|
$ |
— |
|
Cash received from options exercised |
|
$ |
— |
|
|
$ |
19 |
|
|
$ |
— |
|
(1)Intrinsic value represents the difference between the closing stock price on the exercise date and the exercise price, multiplied by the number of options.
|
| Summary of Stock Option Transactions under Plans |
The following is a summary of stock option transactions under the Plans for the periods indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
|
2023 |
|
|
2022 |
|
|
2021 |
|
|
|
Number of
Shares |
|
|
Weighted-
Average
Exercise
Price Per
Share |
|
|
Number of
Shares |
|
|
Weighted-
Average
Exercise
Price Per
Share |
|
|
Number of
Shares |
|
|
Weighted-
Average
Exercise
Price Per
Share |
|
Options outstanding at beginning of period |
|
|
111,000 |
|
|
$ |
19.89 |
|
|
|
115,938 |
|
|
$ |
19.58 |
|
|
|
125,938 |
|
|
$ |
19.59 |
|
Options exercised |
|
|
(50,000 |
) |
|
23.29 |
|
|
|
(1,500 |
) |
|
$ |
12.54 |
|
|
|
— |
|
|
$ |
— |
|
Options forfeited |
|
|
— |
|
|
$ |
— |
|
|
|
— |
|
|
$ |
— |
|
|
|
(10,000 |
) |
|
$ |
19.74 |
|
Options expired |
|
|
— |
|
|
$ |
— |
|
|
|
(3,438 |
) |
|
$ |
12.54 |
|
|
|
— |
|
|
$ |
— |
|
Options outstanding at end of period |
|
|
61,000 |
|
|
$ |
22.73 |
|
|
|
111,000 |
|
|
$ |
19.89 |
|
|
|
115,938 |
|
|
$ |
19.58 |
|
Options exercisable at end of period |
|
|
61,000 |
|
|
$ |
22.73 |
|
|
|
111,000 |
|
|
$ |
19.89 |
|
|
|
115,938 |
|
|
$ |
19.58 |
|
|
| Summary of Stock Options Outstanding under Plans |
As of December 31, 2023, stock options outstanding under the Plans were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options Outstanding |
|
|
Options Exercisable |
|
|
|
Number of
Shares |
|
|
Intrinsic
Value
(1) |
|
|
Weighted-
Average
Exercise
Price Per
Share |
|
|
Weighted-
Average
Remaining
Contractual
Life |
|
|
Number of
Shares |
|
|
Intrinsic
Value
(1) |
|
|
Weighted-
Average
Exercise
Price Per
Share |
|
|
Weighted-
Average
Remaining
Contractual
Life |
|
$20.00 to $21.49 |
|
|
3,000 |
|
|
$ |
(7 |
) |
|
$ |
20.64 |
|
|
|
0.59 |
|
|
|
3,000 |
|
|
$ |
(7 |
) |
|
$ |
20.64 |
|
|
|
0.59 |
|
$21.50 to $23.49 |
|
|
55,000 |
|
|
|
(247 |
) |
|
$ |
22.73 |
|
|
|
0.82 |
|
|
|
55,000 |
|
|
|
(247 |
) |
|
$ |
22.73 |
|
|
|
0.82 |
|
$23.50 to $24.83 |
|
|
3,000 |
|
|
|
(20 |
) |
|
|
24.83 |
|
|
|
1.48 |
|
|
|
3,000 |
|
|
|
(20 |
) |
|
|
24.83 |
|
|
|
1.48 |
|
|
|
|
61,000 |
|
|
$ |
(274 |
) |
|
$ |
22.73 |
|
|
|
0.84 |
|
|
|
61,000 |
|
|
$ |
(274 |
) |
|
$ |
22.73 |
|
|
|
0.84 |
|
(1)
Intrinsic value represents the difference between the closing stock price on the last trading day of the period, which was $19.40 as of December 31, 2023, and the exercise price, multiplied by the number of options. This value is presented in thousands.
|
| Restricted stock awards |
|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|
| Schedule of Restricted Stock Awards and Performance Stock Units under 2013 And 2021 Plan |
The table below provides information for restricted stock awards under the Plans for the periods indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2023 |
|
|
2022 |
|
|
2021 |
|
|
|
Number of
Shares |
|
|
Weighted-
Average
Grant Date
Fair Value
Per Share |
|
|
Number of
Shares |
|
|
Weighted-
Average
Grant Date
Fair Value
Per Share |
|
|
Number of
Shares |
|
|
Weighted-
Average
Grant Date
Fair Value
Per Share |
|
Restricted stock at beginning of period |
|
|
156,174 |
|
|
$ |
21.29 |
|
|
|
152,087 |
|
|
$ |
17.24 |
|
|
|
243,708 |
|
|
$ |
15.60 |
|
Restricted stock granted |
|
|
131,021 |
|
|
$ |
18.86 |
|
|
|
101,271 |
|
|
$ |
24.56 |
|
|
|
75,679 |
|
|
$ |
19.62 |
|
Restricted stock vested |
|
|
(83,968 |
) |
|
$ |
19.34 |
|
|
|
(89,699 |
) |
|
$ |
23.95 |
|
|
|
(134,659 |
) |
|
$ |
16.01 |
|
Restricted stock forfeited |
|
|
(6,782 |
) |
|
$ |
23.08 |
|
|
|
(7,485 |
) |
|
$ |
23.46 |
|
|
|
(32,641 |
) |
|
$ |
15.02 |
|
Restricted stock at end of period |
|
|
196,445 |
|
|
$ |
20.72 |
|
|
|
156,174 |
|
|
$ |
21.29 |
|
|
|
152,087 |
|
|
$ |
17.24 |
|
|
| Performance Stock Units |
|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|
| Schedule of Restricted Stock Awards and Performance Stock Units under 2013 And 2021 Plan |
The table below provides information for performance stock units under the 2021 Plans for the periods indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2023 |
|
|
2022 |
|
|
2021 |
|
|
|
Number of
Shares |
|
|
Weighted-
Average
Grant Date
Fair Value
Per Share |
|
|
Number of
Shares |
|
|
Weighted-
Average
Grant Date
Fair Value
Per Share |
|
|
Number of
Shares |
|
|
Weighted-
Average
Grant Date
Fair Value
Per Share |
|
Performance stock at beginning of period |
|
|
104,599 |
|
|
$ |
18.83 |
|
|
|
66,563 |
|
|
$ |
15.25 |
|
|
|
23,937 |
|
|
$ |
9.65 |
|
Performance stock granted |
|
|
53,696 |
|
|
$ |
21.08 |
|
|
|
38,036 |
|
|
$ |
25.10 |
|
|
|
42,626 |
|
|
$ |
18.40 |
|
Performance stock vested |
|
|
(23,937 |
) |
|
$ |
9.65 |
|
|
|
— |
|
|
$ |
— |
|
|
|
— |
|
|
$ |
— |
|
Performance stock at end of period |
|
|
134,358 |
|
|
$ |
21.37 |
|
|
|
104,599 |
|
|
$ |
18.83 |
|
|
|
66,563 |
|
|
$ |
15.25 |
|
|